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Retinal progenitor cells (RPCs) are programmed early in development to acquire the competence for spec-
ifying the seven retinal cell types. Acquiring competence is a complex spatiotemporal process that is still
only vaguely understood. Here, our objective was to more fully understand the mechanisms by which
RPCs become competent for specifying a retinal ganglion cell (RGC) fate. RGCs are the ﬁrst retinal cell
type to differentiate and their abnormal development leads to apoptosis and optic nerve degeneration.
Previous work demonstrated that the paired domain factor Pax6 and the bHLH factor Atoh7 are required
for RPCs to specify RGCs. RGC commitment is marked by the expression of the Pou domain factor Pou4f2
and the Lim domain factor Isl1. We show that three RPC subpopulations can specify RGCs: Atoh7-express-
ing RPCs, Neurod1-expressing RPCs, and Atoh7–Neurod1-expressing RPCs. All three RPC subpopulations
were highly interspersed throughout retinal development, although each subpopulation maintained a
distinct temporal pattern. Most, but not all, RPCs from each subpopulation were postmitotic. Atoh7–Neu-
rod1 double knockout mice were generated and double-mutant retinas revealed an unexpected role for
Neurod1 in specifying RGC fate. We conclude that RPCs have a complex regulatory gene expression pro-
gram in which they acquire competence using highly integrated mechanisms.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
In the past 20 years, an impressive amount of knowledge has
been generated on molecular regulatory mechanisms that control
retinal development in embryonic and neonatal life (for a recent
review, see Agathocleous & Harris, 2009). Many of these mecha-
nisms have been found to be important in the preservation of the
adult retina as well (Lamba, Karl, & Reh, 2008). Despite this sub-
stantial knowledge database, we still remain woefully uninformed
about many of the fundamental mechanisms that are required to
generate a fully functional neural tissue capable of receiving light
and sending the information to the visual centers in the brain for
visual perception.
Retinal development begins immediately after the presumptive
retinal epithelial layer separates from the presumptive retinal pig-
mented epithelium and retinal progenitor cells (RPCs) arise fromll rights reserved.
Biochemistry and Molecular
r Center, Houston, TX 77030,
lein).
Ross Eye Institute, Center of
ersity of Buffalo, Buffalo, NYpluripotent neural stem cells. RPCs are intrinsically programmed
at very early stages in retinal development to follow certain lineage
paths but they are not yet committed to any of the seven retinal
cell types (Agathocleous & Harris, 2009; Livesey & Cepko, 2001).
Rather, RPCs become competent over developmental time to com-
mit to one or more individual cell types. RPC competency changes
continuously during retinogenesis as the extrinsic environment of
the developing retina changes (Agathocleous & Harris, 2009; Live-
sey & Cepko, 2001). RPC competency is marked by the expression
of transcriptional regulatory factors. Expression of the paired
box-homeodomain factor Pax6 is necessary for the speciﬁcation
of all the retinal cell types except amacrine cells (Marquardt &
Gruss, 2002; Marquardt et al., 2001; Oran-Karni et al., 2008).
Pax6 action is counteracted by the Notch-Delta signaling pathway,
which keeps RPCs in the cell cycle by activating the bHLH tran-
scriptional repressors Hes1 and Hes5 (Agathocleous & Harris,
2009; Riesenberg, Liu, Kopan, & Brown, 2009).
In this present study, we focus on the development of one of the
seven retinal cell types, retinal ganglion cells (RGCs). In the mouse,
as with other vertebrates, RGCs are the ﬁrst cells to differentiate
from RPCs. For RGC commitment to occur, a population of Pax6-
expressing RPCs must downregulate the Notch signaling pathway,
exit the cell cycle, and express the proneural bHLH gene Atoh7 (also
called Math5) (Agathocleous & Harris, 2009; Mu & Klein, 2004,
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fying the RGC lineage.
Lineage analysis has shown that in addition to RGCs, Atoh7-
expressing RPCs can give rise to all the other retinal cell types
(Yang, Ding, Pan, Deng, & Gan, 2003). Indeed, most Atoh7-express-
ing cells are thought not to form RGCs (T. Glaser, unpublished re-
sults). However, retinas of Atoh7-knockout mice lack virtually all
RGCs yet still form all the other retinal cell types (Brown, Patel,
Brzezinski, & Glaser, 2001; Wang et al., 2001). Atoh7 is therefore
necessary but not sufﬁcient for commitment to an RGC fate (Mu
& Klein, 2008; Yang et al., 2003). In the mouse retina, the earliest
signs of overt RGC differentiation are the downregulation of Atoh7
expression and the onset of expression of two key transcription
factors that are essential for normal RGC differentiation to occur.
These are the Pou domain factor Pou4f2 and the Lim domain factor
Isl1 (Gan, Wang, Huang, & Klein. 1999; Mu, Fu, Beremand, Thomas,
& Klein, 2008; Pan, Deng, Xie, & Gan, 2008). Pou4f2, Isl1, and most
likely other early-expressing transcriptional regulators activate a
hierarchical RGC gene regulatory network consisting of more
downstream transcription factors as well as secreted signaling
molecules that feedback to RPCs to maintain a correct balance of
proliferating RPCs and differentiating RGCs (Mao et al., 2008; Mu
& Klein, 2008; Mu et al., 2008).
To fully understand how RPCs give rise to RGCs, more precise
analyses are required than those that have been previously re-
ported. Towards this end, we recently generated a mouse line in
which Atoh7 is replaced with a hemagglutinin (HA) epitope-tagged
knock-in construct (Atoh7-HA) (Fu et al., 2009). Retinal cells
expressing Atoh7-HA can be readily recognized by immunohisto-
chemical methods using an anti-HA antibody. The Atoh7-HA-
knock-in mice provide the means to examine over spatiotemporal
development the relationship of Atoh7-expressing RPCs with other
transcriptional regulators and with markers of cell cycle progres-
sion. Our results show that distinct populations of Atoh7-express-
ing RPCs are present in the developing retina and reveal an
unexpected role for the proneural bHLH gene Neurod1 in specifying
a subpopulation of RGCs. We conclude that RPCs are far more het-
erogeneous than previously thought and that they exhibit a com-
plex regulatory gene expression program in which they acquire
competence using highly integrated mechanisms.2. Methods
2.1. Genetically engineered mice
Atoh7-knockout mice are described in Wang et al. (2001), Neu-
rod1-knockout mice are described in Pennesi et al. (2003), and
Atoh7-HA mice are described in Fu et al. (2009). Atoh7–Neurod1-
double heterozygous and double homozygous mice were gener-
ated by breeding single mutant heterozygous and homozygous
mice. Mice were genotyped by Southern blot analysis or PCR using
tail DNA as previously described (Fu et al., 2009). Embryos were
designated embryonic day (E) 0.5 at noon on the day in which vag-
inal plugs were observed.
All animal procedures in this study follow the United States
Public Health Service Policy on Humane Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee at The University of Texas MD Anderson Cancer
Center.2.2. Immunohistochemical analysis and X-gal staining
Embryos or eyes were collected and ﬁxed with 4% paraformal-
dehyde for 30 min, washed three times with PBST (PBS pH7.4,
0.2% Tween 20), embedded in OCT and frozen. Sixteen-microncryosections were collected, washed three times for 10 min with
PBST, and blocked with 2% BSA in PBST for 1 h. For some staining,
frozen or parafﬁn-embedded sections were placed in a microwave
oven at 600W in 10 mM sodium citrate for 18 min to expose the
antigen epitopes, and then blocked in 10% normal serum and
0.1% Tween 20 for 1 h at room temperature. The sections were then
incubated with primary antibodies with appropriate dilution in 2%
BSA-PBST for 1 h. X-gal staining was done as described elsewhere
(Mao et al., 2008). Primary antibodies were anti-HA (Santa Cruz,
1:800), anti-Pax6 (DSHB, 1:400), anti-Chx10 (Exalpha, 1:300, Cov-
ance, 1:1000), anti-NeuroD (Santa Cruz Biotechnology, 1:400),
anti-cyclinD1 (Cell Signaling, 1:300), anti-lacZ (Cell Signaling,
1:400), anti-Chat (Swant, 1:500), anti-calbindin (Swant, 1:500),
anti-glutamate synthase (Sigma, 1:300), anti-rhodopsin (Cell Sig-
ma, 1:500), anti-NFL (InVitrogen, 1:200), anti-B-opsin and anti-R-
opsin (1:500, Chemicon). Secondary antibodies were conjugates
of Alexa Fluor 488 and Alexa Fluor 555 (InVitrogen). Secondary
antibodies were conjugates of Alexa Fluor 488 and Alexa Fluor
555 (Invitrogen). DAPI (40,6-diamidino-2-phenylindole) or PI (pro-
pidium iodide) were used as a nuclear counterstain. Sections were
washed with PBST and mounted in Fluoromount G (EMS) and
examined under a confocal microscope.
2.3. BrdU labeling
For BrdU labeling, 0.1 mg of BrdU per g body weight was in-
jected intraperitoneally into pregnant mice one hour prior to
euthanization. Embryos were ﬁxed and washed for immunohisto-
chemistry, embedded in OCT and frozen. Sixteen-micron of cryo-
section were washed three times with PBST for 10 min followed
by 4 N HCl treatment for 1 h. Sections were washed three times
with PBST for 10 min and incubated with anti-BrdU antibody (Up-
state, 1:5). Alexa 488-conjugated anti-mouse IgG antibody was
used for secondary antibody labeling.
2.4. Retina ﬂat-mount analysis
To detect RGC axons, eyes were removed from postnatal mice
and ﬁxed with 4% paraformaldehyde for 30 min. The cornea, ciliary
band, and lens were removed using a pair of iris scissors. The
remaining retinal tissue and attached pigmented epithelium were
ﬁxed for 1 h and then washed four times in PBS saline and 0.1% Tri-
ton X-100 at room temperature. The retinas were then incubated
in blocking solution (PBST plus 5% fetal bovine serum) for 1 h,
and incubated with anti-NFL (1:250) for 48 h at 4 C. Retinas were
washed four times with PBST and stained with Alexa 488-conju-
gated goat anti-mouse IgG1 secondary antibody (Invitrogen). After
washing thoroughly with PBS, the pigmented epithelium was re-
moved from the retinas and four or ﬁve symmetrical cuts were
made halfway from the peripheral rim to the central optic disk.
Retinas were then ﬂat-mounted onto glass slides and analyzed
using an Olympus FluoView1000 confocal microscope.
2.5. Determination of cell number
Cell number was determined by cell counting as described pre-
viously (Mu et al., 2005). Sections from three individual retinas
were used for each staining. Two confocal images of central retinal
region from each section were taken and cells stained in the neu-
roblast layer were counted. The neuroblast layer was determined
based on morphology. Number of HA-expressing cells was repre-
sented as a fraction of cells stained with HA antibody per cells
stained with PI. For co-immunostaining, numbers of cells were rep-
resented as fractions of cells stained by HA and Pax6, Chx10 or
NeuroD1 antibodies per cells stained by HA antibody.
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3.1. Characterization of Atoh7-HA expression with an anti-HA
antibody
Because a robust anti-Atoh7 antibody for immunohistochemis-
try is not available, we recently generated and characterized Atoh7-
HA knock-in mice, which could then be used to detect Atoh7-
expression with any number of well-described, commercially
available anti-HA antibodies (Fu et al., 2009). To determine
whether immunohistochemical labeling with anti-HA antibody
accurately reﬂected endogenous Atoh7 expression in developing
retinas, we made use of Atoh7-lacZ knock-in mice that had been
previously generated in our laboratory (Wang et al., 2001). E14.5
retinas from Atoh7lacZ/HA heterozygous mice were immunohisto-
chemically labeled with anti-HA antibody and histologically
stained for X-gal (Fig. 1A). HA-positive cells were detected in the
neuroblast layer but not in the ganglion cell layer, whereas lacZ-
stained cells were present in both the neuroblast and ganglion cell
layers (Fig. 1A). In the neuroblast layer, approximately 65% of the
HA-labeled cells were also labeled with lacZ. However, 35% of
the HA-positive cells were not co-labeled with lacZ, and similarly,
we observed lacZ-positive cells that were not labeled with HAFig. 1. Expression of HA and lacZ in Atoh7HA/lacZ retinas. (A) Atoh7HA/LacZ retinas at
E14.5 were immunohistochemically labeled with anti-HA antibody (brown) and
histological stained for X-gal (blue). The ganglion cell layer is at the bottom on the
image. (B) Histogram showing the temporal expression pattern of Atoh7-HA in the
neuroblast layer of developing retinas. Atoh7-expressing cells from E12.5 to E19.5
were detected by immunolabeling retinas with anti-HA antibody. To identify cells,
their nuclei were stained with propidium iodide (PI). The number of HA-positive
cells and nuclei in the neuroblast layer were quantiﬁed as described in Section 2.
The HA-positive cells are calculated as a fraction of total cells in the neuroblast layer
(n = 3).(Fig. 1A). HA-positive cells were found distributed throughout
the neuroblast layer, while lacZ-positive cells accumulated more
in the ventricular region than the central region of the neuroblast
layer. Because lacZ is known to be a highly stable protein, the dif-
ferences observed between HA-positive cells and lacZ-positive
cells might reﬂect differences in the stabilities of lacZ and Atoh7-
HA proteins. The stability of the Atoh7-HA fusion protein was
likely to be more similar to that of Atoh7, which is thought to have
a higher turnover rate than lacZ (Fu et al., 2009; Wang et al., 2001).
If this was the case, Atoh7-HA labeling would be indicative of cells
expressing Atoh7 in a narrower time window than those express-
ing lacZ, whose expression might reﬂect the more long-term his-
tory of cells that once expressed Atoh7 but were no longer doing
so. Despite this caveat, the majority of cells in the neuroblast layer
of E14.5 retinas were co-labeled with HA and lacZ, supporting the
view that the anti-HA antibody was a suitable proxy for Atoh7-
expressing cells.
Atoh7-HA mice provide a means to determine many of the fea-
tures of Atoh7-expressing RPCs that have been difﬁcult to deter-
mine by other methods. For example, neither the time when
Atoh7 exerts its activity or the fraction of Atoh7-expressing RPCs
in the neuroblast layer of the developing retina has been accurately
determined. If Atoh7-HA expression does in fact accurately reﬂect
Atoh7-expression, it is reasonable to assume that all the rates asso-
ciated with the synthesis, processing, and degradation of Atoh7-HA
mRNA and protein are the same as the corresponding rates for
Atoh7 mRNA and protein. To obtain a clearer picture of the tempo-
ral expression pattern of Atoh7 and number of Atoh7-expressing
RPCs, we immunolabeled retinas at different developmental times
with anti-HA antibody. In E12.5 retinas, approximately 20% of cells
in the neuroblast layer were HA positive (Fig. 1B). The fraction of
cells expressing Atoh7-HA increased until E14.5, when 27% of the
cells in the neuroblast layer were expressing Atoh7-HA. The frac-
tion of HA-positive cells then rapidly declined; only 8% of the cells
were HA positive at E17.5, and only 2% were positive at E19.5
(Fig. 1B). HA-positive cells were not detected in adult retinas (date
not shown). These results were consistent with and considerably
extend those reported previously (Brown et al., 1998; Wang
et al., 2001; Willardsen et al., 2009).
3.2. Atoh7-HA-expression in proliferating RPCs
Two previously published reports differed on when in the cell
cycle RPCs are expressing Atoh7. One study using Atoh7-Cre and
Rosa26-lacZ expression to determine the lineage of Atoh7-express-
ing RPCs found that all Atoh7-expressing RPCs were postmitotic
(Yang et al., 2003). However, a second study using an Atoh7-lacZ
knock-in line and antibodies against the cell cycle kinase inhibitor
p27/Kip1 found that Atoh7 was expressed in cells exiting the cell
cycle, and in fact was required for cell cycle exit to occur normally
(Le, Wroblewski, Patel, Riesenberg, & Brown, 2006). In an attempt
to resolve these differences and determine more directly whether
Atoh7 was expressed in proliferating RPCs, we co-labeled develop-
ing retinas with anti-HA and anti-Chx10 antibodies. Chx10 is a
homeobox transcription factor that is required for RPC prolifera-
tion and for bipolar cell development (Burmeister et al., 1996;
Dyer, 2003; Hatakeyama, Tomita, Inoue, & Kageyama, 2001; Liang
& Sandell, 2008). From E12.5 to E19.5, Chx10-positive cells were
observed uniformly distributed throughout the neuroblast layer
(Fig. 2A–D). During these times, HA-positive cells were detected
both in Chx10-positive and Chx10-negative cells (Fig. 2A–D). The
fraction of HA-positive cells co-expressing Chx10 ranged from
20% to 30% from E12.5 until E18.5, and declined to 8% at E19.5
(Fig. 3). In contrast to the earlier studies of Yang et al. (2003) and
Le et al. (2006), our results indicated that many Atoh7-expressing
RPCs were actively proliferating. The reason for the discrepancies
Fig. 2. Co-expression of HA and Chx10 in developing retinas. (A–D) Retinas co-labeled with anti-HA (red) and anti-Chx10 (green) antibodies at the indicated developmental
stages. (E–G) Double labeling of Chx10 and HA in E14.5 retina. Stained retinas are represented as HA-staining (E), Chx10 staining (F) and merge (G). Cells co-labeled with HA
and Chax10 antibodies are indicated by an arrow head.
Fig. 3. Histogram showing the fraction of Atoh7-expressing RPCs in the neuroblast
layer of the developing retinas that are co-expressing Pax6 (blue–gray), Chx10 (red)
or Neurod1 at the indicated developmental times. Anti-HA, anti-Pax6, and anti-
Neurod1 antibodies were used to label the retinas (n = 3) and the fraction of cells
expressing the indicated transcription factor was determined as described in
Section 2. Fig. 4. Co-expression of Atoh7-HA with cell cycle markers. Retinas at E14.5 were
immunolabeled with anti-HA antibody (red) and antibodies against BrdU (A),
cyclinD1 (B), or p27 (C) (green). Cells co-labeled with anti-HA and anti-BrdU, anti-
CyclinD1 or anti-p27 antibodies are indicated by the arrowheads.
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and anti-Chx10 antibody co-labeling, which was clearly distinct
from the approaches used in the other studies. It is possible that
HA labeling overestimates the number of Atoh7-expressing RPCs
that are in the cell cycle while the other approaches underestimate
this value.
To conﬁrm our results with Chx10, we used other cell cycle
indicators in conjunction with anti-HA antibody labeling. BrdU
was used to determine the number of Atoh7-expressing RPCs that
were in the S-phase of the cell cycle. Cells positive for both HA
and BrdU and cells positive for HA but not BrdU were observed
in the neuroblast layer (Fig. 4A). Approximately 25% of the HA-po-
sitive cells were co-labeled with anti-BrdU antibody. We observed
a similar labeling pattern using anti-cyclinD1 antibody, which
marks the G-phase of the cell cycle (Fig. 4B). Approximately 25%
of the HA-positive cells were co-labeled with anti-cyclinD1. We
also used an anti-p27 antibody (Fig. 4C). In this case, approxi-
mately half of the HA-positive cells were also labeled with anti-
p27 antibody. These results differ substantially from those ob-
served by Le et al. (2006) using an anti-p27 antibody and lacZ
expression. In contrast to Yang et al. (2003) and Le et al. (2006),our experiments suggested that although the majority of Atoh7-
expressing RPCs in the developing retina were postmitotic, many
were also in RPCs that were actively dividing.3.3. Co-expression of Atoh7 with Pax6
Pax6 and Atoh7 are essential for RGC development, yet the rela-
tionship between these two critical transcription factors during
retinal development is only vaguely understood. A recent report
describes a cis-regulatory element upstream of Atoh7 whose activ-
ity depends on Pax6, suggesting that Atoh7 is a direct Pax6 target
gene (Riesenberg et al., 2009). To further address this issue, we
determined the extent to which Pax6 and Atoh7 were co-expressed
during retinal development by co-labeling retinas at different
developmental times with anti-Pax6 and anti-HA antibodies. At
E12.5, almost 90% of the cells in the neuroblast layer of the retina
that were expressing Atoh7-HA were also expressing Pax6 (Figs. 3
and 5A). The fraction of Atoh7-HA-expressing cells that were also
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tion had decreased to 45% and continued to steadily decline to 42%,
30%, and 23% by E15.5, E16.5, and E17.5, respectively (Figs. 3 and
5A–C). At E18.5 and E19.5, no co-labeling was observed (Figs. 3
and 5D). These results reinforced the view that during the critical
times when RPCs are acquiring competence to specify an RGC fate,
the expression of both Pax6 and Atoh7 is required.3.4. Co-expression of Atoh7 with Neurod1
Neurod1 is a proneural bHLH factor that shares signiﬁcant se-
quence similarity to Atoh7 (Mao, Wang, Pan, & Klein, 2008; Vetter
& Brown, 2001). In retinal development, Neurod1 has been shown
to be necessary for amacrine cell formation and for the mainte-
nance of rod photoreceptor cells (Inoue et al., 2002; Pennesi
et al., 2003). Using a gene knock-in construct designed for gene
replacement at the Atoh7 locus, we recently demonstrated that
Neurod1 could partially replace the functions of Atoh7 when it is
expressed at the same time and place as Atoh7 (Mao et al., 2008).
One interpretation of our results was that Neurod1 played some
role in RGC development in addition to its other roles in amacrine
cell development and rod photoreceptor maintenance. We hypoth-
esized that the functions for Atoh7 and Neurod1 as well as for other
proneural bHLH factors expressed during retinogenesis were far
more synergestic and integrated than what had previously been
suggested (Mao et al., 2008).Fig. 5. Co-expression of Atoh7 with Pax6 (A–D) or Neurod1 (E–H). Retinas at the indicat
anti-Neurod1 (green) antibodies.To gain further insight into the possible interactions between
Atoh7 and Neurod1, we co-labeled developing retinas with anti-
HA and anti-Neurod1 antibodies. At E12.5, we detected HA-posi-
tive cells and Neurod1-positive cells distributed throughout the
neuroblast layer (Fig. 5E). By E14.5, Neurod1-positive cells were
largely restricted to the outer nuclear layer and this pattern was
maintained as development proceeded (Fig. 5G–H). Throughout
development, we found that 20–30% of HA-positive cells were also
Neurod1-positive (Figs. 3 and 5E–H). The results indicated that a
signiﬁcant population of Atoh7-expressing RPCs was also express-
ing Neurod1, and provided further support to the notion that Neu-
rod1 played a role in RGC development.3.5. Generation and characterization of Atoh7–Neurod1 double
knockout mice
Despite the importance of Atoh7 in specifying RGC fate, a small
fraction of seemingly normal RGCs persist in Atoh7-null retinas
(Lin, Wang, & Masland, 2004; Moshiri et al., 2008). These experi-
ments, together with our recent results showing that Neurod1
could replace Atoh7, suggested the possibility of an Atoh7-indepen-
dent program that required Neurod1 to generate a small subpopu-
lation of RGCs. To determine whether this was the case, we
generated Atoh7–Neurod1 double knockout mice and compared
their retinas with Atoh7-null retinas. Adult retinas from Atoh7–
Neurod1 double knockout mice maintained their laminar integrityed developmental times were immunolabeled with anti-HA (red) and anti-Pax6 or
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wild-type retinas (Fig. 6). Overall retinal thinness is often a sign
of decreased RPC proliferation or increased apoptosis during reti-
nal development.
To determine whether any of the retinal cell types were affected
in the double-mutant retinas, we immunohistochemically labeled
adult retinas with a number of antibodies that labeled speciﬁc ret-
inal cell types, namely, anti-Chat (amacrine cells, Fig. 6A–C), anti-
M-opsin (M-cone photoreceptors, Fig. 6A–C), anti-NFL (RGCs,
Fig. 6D–F), anti-S-opsin (S-cone photoreceptors, Fig. 6D–F), anti-
glutamine synthase (GS) (Müller glial cells, Fig. 6G–I), anti-rhodop-
sin, (rod photoreceptors, Fig. 6J–L), Chx10 (bipolar cells, Fig. 6M–
O), and anti-calbindin (horizontal cells, Fig. 6M–O).
We detected a signiﬁcant decrease in the number of M-cone
photoreceptors in double-mutant retinas (none detectable) com-
pared with Atoh7-null (65.33 ± 6.11 or wild-type retinas
(91.67 ± 4.04 (Fig. 6A–C). The loss of M-cone photoreceptors in
Neurod1-knockout mice has recently been found to be associated
with an overproliferation of S-cone photoreceptors at the expense
of M-cone photoreceptors, yet we did not detect a difference in the
number of M-cone cells between the Neurod1/ and double mu-
tants (Liu et al., 2008). Other additional defects were also seen in
Atoh7–Neurod1 double-mutant retinas; e.g., calbindin-positiveFig. 6. Retinal cell types in Atoh7+/ (left panels), Atoh7/ (middle panels) and Atoh7–
immunohistochemical labeling with the indicated antibody: anti-Chat, amacrine cells (
green), anti-S-opsin, S-cone photoreceptors (D–F, red), anti-glutamine synthase (GS), M
bipolar cells (M–O, green), and anti-calbindin, horizontal cells (M–O, red). Scale bar in pamacrine cells were decreased in the inner nuclear layer of dou-
ble-mutant retinas (217 ± 25.53) compared to that in control reti-
nas (272 ± 7.55). These data suggested that Atoh7 does not
compensate for Neurod1 in cone cell formation. In addition, the
perinuclear condensation of rhodopsin that we observed in the
rod photoreceptors of the double mutants (Fig. 6L) was a sign of
rod photoreceptor degeneration, which has been previously re-
ported in Neurod1-null retinas by Pennesi et al. (2003).
Importantly, we also observed a signiﬁcant decrease in NFL
expression in Atoh7–Neurod1 double-mutant retinas compared
with Atoh7-null retinas (Fig. 6E and F). Although NFL expression
was strongly downregulated in Atoh7-null retinas compared with
wild-type controls (Fig. 6D and E), the diminishment of NFL
expression was even more pronounced in the double-mutant reti-
nas (Fig. 6F). These results indicated that the loss of RGCs was even
greater in Atoh7–Neurod1 double-mutant retinas than in Atoh7-
null retinas. This was particularly interesting because RGCs devel-
op normally in Neurod1-null mice (Pennesi et al., 2003).
We determined the number of RGCs in double-mutant retinas
more directly using ﬂat-mounted retina preparations that were
immunolabeled with anti-NFL antibody to detect RGC axons
(Fig. 7A–D). We detected signiﬁcantly fewer RGC axons in dou-
ble-mutant retinas than in Atoh7-null retinas (compare Fig. 7A,Neurod1 double mutant (right panels) retinas at P35. Cell types were identiﬁed by
A–C, green), anti-M-opsin, M-cone photoreceptors (A–C, red), anti-NFL RGCs (D–F,
üller glial cells (G–I, red), anti-rhodopsin rod photoreceptors (J–L, green), Chx10,
anels A, J, 50 lm.
Fig. 7. Atoh7–Neurod1 double-mutant retinas contain fewer RGC axon ﬁbers than
do Atoh7 mutant retinas. (A and B) Immunolabeling of ﬂat-mounted retinas from
P30 mice with anti-NFL antibody to reveal RGC axons. Genotypes are indicated on
the upper left of each panel. (C and D) Enlarged images of boxed areas in panels A
and B highlight the reduced number of axon ﬁbers in Atoh7–Neurod1 double
mutants. OD, optic disk.
Fig. 9. Apoptosis analysis in E14.5 Atoh7 and Neurod1 mutant retinas. (A) Atoh7+/;
Neurod1+/, (B) Atoh7/; Neurod1+/, (C) Atoh7+/; Neurod1/, and (D) Atoh7/;
Neurod1/ retinas. Note that a slight increase of cell death is always found in
Atoh7/; Neurod1/ retinas than in control retinas. Arrowheads indicate dying
cells. Scale bar in D, 100 lm.
T. Kiyama et al. / Vision Research 51 (2011) 251–259 2577C with Fig. 7B and D). To determine whether the enhanced RGC
phenotype is due to a speciﬁcation or a maintenance defect, we
immunostained E13.5 retinal sections with an anti-Pou4f2 anti-
body. We found that the remaining few Pou4f2-positive cells in
the Atoh7 mutant were completely abolished in the Atoh7–Neuo-
rod1 double mutant (Fig. 8B and C). Furthermore, we conducted
apoptosis analysis on mutant retinas, and found a slight increase
of dying cells in the Atoh7–Neurod1 double mutant compared to
that of the control (Fig. 9). The results were consistent with our
hypothesis that Neurod1 contributed to RGC development and that
it was required for the formation of a subpopulation of RGCs that
formed in the absence of Atoh7.
4. Discussion
The ability to generate mouse models using targeted gene
knockout technology has resulted in major advances in our under-
standing of the mechanisms that regulate retinal development
(e.g., Chalupa & Williams, 2008). In the present study, we made
use of two genetically engineered mouse lines, one that expressedFig. 8. Pou4f2 expression in E13.5 Atoh7 and Neurod1 mutant retinas. (A) Atoh7+/; Neuro
100 lm.an Atoh7-HA allele at the Atoh7 locus and another that lacked both
the Atoh7 and Neurod1 genes. The experiments described in this re-
port relied on these mouse lines to provide new insights into RPCs
and how they acquire the competency for specifying the retinal cell
types. The results lead to the conclusion that RPCs are far more
complicated in their expression of regulatory genes than previ-
ously thought. Furthermore, regulatory genes expressed in RPCs
are likely to be synergistic and to operate in complex combinations
to advance a competent RPC to a committed retinal cell type.
Immunolabeling with anti-HA antibody allowed us to deter-
mine the spatiotemporal expression pattern of Atoh7 and the frac-
tion of RPCs that express Atoh7 during retinal development. We
found that Atoh7 was expressed in a narrow window of time, with
expression peaking at E14.5 and rapidly declining thereafter. At
E12.5, the earliest time we examined, Atoh7-expressing RPCs al-
ready represented 20% of the cells in the neuroblast layer, and at
its peak, Atoh7was expressed in more than one-quarter of the cells.
Thus, Atoh7 must be activated at very early times in retinal devel-
opment and Atoh7-expressing RPCs must make a signiﬁcant contri-
bution to the initial but not ﬁnal stages of retinogenesis. This is
particularly interesting because most Atoh7-expressing RPCs are
not destined to follow an RGC fate (Yang et al., 2003). Earlier re-
ports have shown that Atoh7 has additional functions besides thosed1+/, (B) Atoh7/; Neurod1+/, and (C) Atoh7/; Neurod1/ retinas. Scale bar in C,
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out and other loss-of-function approaches (Brown et al., 2001; Le
et al., 2006; Wang et al., 2001). We favor a model in which
Atoh7-expressing RPCs play critical roles in broader aspects of ret-
inal cell type speciﬁcation, especially at early times in retinogene-
sis. Atoh7 is likely to work together with Pax6 and other
transcription factors in deﬁning one subpopulation of RPCs during
these times.
An unexpected ﬁnding from our experiments was that in addi-
tion to postmitotic RPCs, a fraction of proliferating RPCs also ex-
press Atoh7. Although our results appear to contradict previous
studies (Le et al., 2006; Yang et al., 2003), they are consistent with
a model in which proliferating RPCs activate Atoh7 expression and
that this activation is closely coupled to cell cycle exit. The time in
the cell cycle when Atoh7 is expressed may be highly sensitive to
the method of detection. Because a robust antibody for Atoh7 is
not available and in situ hybridization is limited by the abundance
of Atoh7 transcripts and technical difﬁculty in double labeling with
cell cycle markers, less direct methods are required. Nevertheless,
all experiments reported to date are consistent with a model in
which the majority of Atoh7-expressing RPCs are just exiting or
have exited the cell cycle.
Pax6 plays a broader role in retinal development than Atoh7
(Marquardt & Gruss, 2002) and is positioned genetically upstream
of Atoh7 in a model for a RGC gene regulatory network that we
have proposed (Mu & Klein, 2008; Mu et al., 2008). The Pax6-HA
co-labeling experiments further support the view Pax6 and Atoh7
must be co-expressed in the same RPC in order for it to acquire
competency for an RGC fate. It is also likely that co-expression of
Pax6 and Atoh7 is important for the formation of other retinal cell
types, although this remains to be shown.
Kageyama and co-workers have proposed that retinal cell-fate
speciﬁcation is regulated by combinations of bHLH and homeobox
genes. In their model, homeobox genes confer positional identity
whereas bHLH genes promote neuronal cell-fate speciﬁcation
(Hatakeyama & Kageyama, 2004; Hatakeyama et al., 2001; Ohsawa
& Kageyama, 2008). Some bHLH factors are known to function as
transcriptional activators (e.g., Atoh7, Neurod1) and others as tran-
scriptional repressors (e.g., Hes1, Hes5). In addition, bHLH factors
regulate each other’s expression (Le et al., 2006; Mu et al., 2005;
Ohsawa & Kageyama, 2008). In RPCs of the developing retina, these
interactions occur in dynamic spatiotemporal patterns. It is there-
fore likely that an exceeding complicated transcriptional network
regulates retinal development.
Earlier work suggested that Neurod1-expressing and Atoh7-
expressing RPCs are largely distinct populations with differing spa-
tiotemporal expression patterns (Inoue et al., 2002; Mu et al.,
2005). Our results indicate that there is a substantial number of
RPCs that co-express Neuod1 and Atoh7. Thus, three distinct sub-
populations of RPCs co-exist during the early stages of retinal
development, Atoh7-expressing RPCs, Neurod1-expressing RPCs,
and Atoh7–Neurod1-expressing RPCs.
We showed previously that a Neurod1 knock-in construct in-
serted at the Atoh7 locus resulted in partial, but not full, activation
of the RGC gene regulatory network and restoration of RGCs and
the optic nerve (Mao et al., 2008). The close relatedness of Neurod1
and Atoh7 sequences in their bHLH domains indicates that these
transcription factors may have extensive overlap in the gene regu-
latory networks that they activate. However, Neurod1 is thought to
play different roles in retinal cell-fate speciﬁcation than those
played by Atoh7. Neurod1 and a related bHLH gene, Math3, are re-
quired together for amacrine cell-fate speciﬁcation (Inoue et al.,
2002). The fact that many RPCs co-express Neurod1 and Atoh7,
and that fewer RGCs are present in Atoh7–Neurod1 double knock-
out retinas compared with Atoh7 single knockout retinas, strongly
argues that Neurod1 plays a role in RGC development. Neurod1maysynergize with Atoh7 to promote RGC speciﬁcation, and in addi-
tion, Neurod1 may be required for the development of a subpopu-
lation of RGCs that form independently of Atoh7.
Recently, we demonstrated a role for the neuronal transcrip-
tional repressor REST/NRSF in retinal development (Mao, Tsai, Bar-
ton, & Klein, in preparation). REST/NRSF is an engrailed domain-
containing transcriptional repressor that represses the expression
of neuronal differentiation genes in non-neuronal cells, pluripotent
stem cells, and neuronal progenitors (Kagalwala, Singh, & Majum-
der, 2008). Six3-Cre-mediated deletion of a ﬂoxed REST/NRSF allele
leads to the efﬁcient deletion of REST/NRSF in the developing retina
beginning at E10.5 (Mao et al., in preparation). We found that in
the absence of REST/NRSF, many of the genes that are normally ex-
pressed in differentiated RGCs are prematurely activated in prolif-
erating RPCs (Mao et al., in preparation). Most importantly, the
premature expression of RGC genes was independent of Atoh7, as
shown by the expression of some of the genes in RPCs of Atoh7-
REST/NRSF double knockout retinas. These results led to the
hypothesis that a distinct pathway for formation of a subpopula-
tion of RGCs exists in the developing retina. This pathway is sup-
pressed by REST/NRSF and does not depend on the presence of
Atoh7. From the results presented here, we suggest that Neurod1
is required for the Atoh7-independent pathway to operate.
In summary, our results provide further demonstration of the
complexity of the gene regulatory networks that are required for
retinal development. Emerging new technologies using next gener-
ation genomic and cDNA sequencing offer a potentially valuable
way to identify the downstream components of retinal gene regu-
latory networks. A more detailed picture of these networks and the
crucial nodes within them should eventually lead to a more com-
prehensive understanding of the molecular programs that regulate
retinal cell-fate speciﬁcation and to how these programs are al-
tered by the continuously changing extrinsic environment of the
developing retina.Acknowledgments
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